x

Society

If Trials Succeed, Greece Will Get 3 Million COVID-19 Vaccine Doses

As scientists around the world have scrambled to find a vaccine for COVID-19, Greece is set to get three million doses of a formula developed by the University of Oxford in collaboration with AstraZeneca if it passes a clinical trial.

Health minister Vassilis Kikilias said trials by the United Kingdom company have reached a third phase and a fourth is needed to see if the vaccine is effective and safe, with research and development on an unparalleled scale.

“At the end of December, January, February, March, May and June, if all goes well, Greece will receive in seven partial deliveries its allocation from the agreed vaccine,” he told broadcaster SKAI.

“We will start with 700,000 doses in December which will be a single or double dose, and around 3 million doses in total,” he added. He didn't say how it would be determined who has priority for the shots in a country of 11 million people.

The shot, called AZD1222 or ChAdOx1 nCoV-19, is a recombinant viral vector vaccine developed by Oxford University. It was licensed to AstraZeneca in April.

RELATED

COPENHAGEN, Denmark — A gunman opened fire inside a busy shopping mall in the Danish capital Sunday, killing three people and critically wounding three others, police said.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

TNΗ’s Happenings of the Week by Eraklis Diamataris

NEW YORK – The National Herald’s Happenings of the Week as have been reported at the print and digital editions of TNH and presented by the TNH Editor Eraklis Diamataris.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.